何洋;张婧;马静;赵伟鹏;王浩;贾晓晨;佟仲生

• 1:天津市肿瘤医院乳腺肿瘤内科，天津市肿瘤医院空港医院乳腺肿瘤内科，国家肿瘤临床医学研究中心，天津市"肿瘤防治"重点实验室，天津市恶性肿瘤临床医学研究中心，天津 300060

摘要(Abstract)：

关键词(KeyWords)： 肿瘤/药物治疗;指纹缺失;皮纹病;手足综合征

Abstract:

Keywords:

基金项目(Foundation): 天津市自然科学基金（18JCYBJC91600）；天津市肿瘤医院科研基金（1513）

作者(Authors): 何洋;张婧;马静;赵伟鹏;王浩;贾晓晨;佟仲生

DOI: 10.13267/j.cnki.syzlzz.2021.073

参考文献(References)：

• [1] Chavarri-Guerra Y, Soto-Perez-de-Celis E. Loss of fingerprints[J]. New Engl J Med, 2015, 372(16):e22.、
  [2] Chen AP, Setser A, Anadkat MJ, et al. Grading dermatologic adverse events of cancer treatments:the Common Terminology Criteria for Adverse Events Version 4.0[J]. J Am Acad Dermatol, 2012, 67(5):1025-1039.
  [3] Yoon S, Jain AK. Longitudinal study of fingerprint recognition[J]. Proc Natl Acad Sci, 2015, 112(28):8555-8560.
  [4] Hober R, Helou J, Korkomaz J, et al. Absence of fingertips with focus on dermatological etiologies; National survey and review[J]. Clin Exp Dermatol, 2015, 3(1):21-26.
  [5] Degen A, Alter M, Schenck F, et al. The hand-foot-syndrome associated with medical tumor therapy-classification and management[J]. J Dtsch Dermatol Ges, 2010, 8(9):652-661.
  [6] van Doorn L, Veelenturf S, Binkhorst L, et al. Capecitabine and the risk of fingerprint loss[J]. JAMA Oncol, 2017, 3(1):122-123.
  [7] van Doorn L, Veelenturf S, Binkhorst L, et al. Capecitabine and the risk of fingerprint loss[J]. JAMA Oncol, 2017, 3(1):122-123.
  [8] Yaghobi Joybari A, Azadeh P, Ghiasi HA, et al. Capecitabine induced fingerprint changes[J]. J Clin Pharm Ther, 2019, 44(5):780-787.
  [9] Azadeh P, Dashti-Khavidaki S, Joybari AY, et al. Fingerprint changes among cancer patients treated with paclitaxel[J]. J Cancer Res Clin Oncol, 2017, 143(4):693-701.
  [10] Negri FV, De Giorgi A, Bozzetti C, et al. Fingerprint change:not visible, but tangible[J]. J Forensic Sci, 2017, 62(5):1372-1373.
  [11] Zhao J, Zhang X, Cui X, et al. Loss of fingerprints as a side effect of capecitabine therapy:case report and literature review[J]. Oncol Res, 2020, 28(1):103-106.
  [12] 万梦婕, 唐梅娟, 杨晓阳. 抗肿瘤药物皮肤不良反应表现[J]. 实用肿瘤杂志,2021,36(1):94-97.
  [13] Cohen PR. Capecitabine-associated loss of fingerprints:report of Capecitabine-induced Adermatoglyphia in two women with breast cancer and review of acquired dermatoglyphic absence in oncology patients treated with Capecitabine[J]. Cureus, 2017, 9(1):e969.